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Abstract
Background: The high doses of zinc oxide (ZnO) administered orally to piglets for the prevention of diarrhea and
increase of growth rate can contaminate pig farms and the surrounding environment. Therefore, there is a need to
find a replacement of high doses of dietary ZnO with an equally effective alternative. In the present study, the
effect of two formulations of zinc phosphate-based nanoparticles (ZnA and ZnC NPs) on growth performance,
intestinal microbiota, antioxidant status, and intestinal and liver morphology was evaluated. A total of 100 weaned
piglets were randomly divided into 10 equal groups with the base diet (control) or the base diet supplemented
with ZnA, ZnC, or ZnO at concentrations 500, 1000, and 2000 mg Zn per kilogram of diet. Supplements were given
to animals for 10 days. Fecal samples were collected on day 0, 5, 10 and 20. At the end of the treatment (day 10),
three piglets from each group were sacrificed and analyzed.
Results: Comparing to that of control, the significantly higher piglet weight gain was observed in all piglet groups
fed with ZnA (P < 0.05). Differences in the total aerobic bacteria and coliform counts in piglet feces after NPs
supplementation compared to that of control and ZnO groups were also found (P < 0.05). The majority of aerobic
culturable bacteria from the feces represented Escherichia (28.57–47.62%), Enterococcus (3.85–35.71%), and
Streptococcus (3.70–42.31%) spp. A total of 542 Escherichia coli isolates were screened for the virulence genes STa,
STb, Stx2, F4, and F18. The substantial occurrence of E. coli virulence factors was found on day 5, mainly in fimbrillary
antigen and thermostable toxins, except for piglets fed by ZnC. Zn treatment decreased Zn blood levels in piglets
fed with ZnO and ZnA (500 mg/kg) and increased in ZnC (2000 mg/kg) compared to that of control (P < 0.05). The
antioxidant status of piglets was affected only by ZnA. While some changes in the liver and the intestinal
morphology of piglets with NPs were observed, none were serious as reflected by the normal health status and
increased weigh gain performance.
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Conclusions: Our results indicate that ZnA NPs have a positive effect on the piglet growth performance even at
the lowest concentration. The prevalence of E. coli virulence factors was lowest in pigs supplemented with ZnC.
Zinc phosphate-based nanoparticles may be an effective alternative to ZnO.
Keywords: Antioxidant status, Diet, E. coli STa, STb, Stx2, F4, F18, Fecal coliforms, Microbiota
Background
Zinc is an essential trace element for animals as it plays
an important role in nutrition, growth, and immunity.
Due to its efficiency and a reasonable price, zinc in the
form of zinc oxide (ZnO) has been commonly used in
high doses (2000 to 3000mg/kg diet) for weaned piglets
as an alternative to antibiotics to prevent intestinal in-
flammation and increase weight gain [1, 2]. However,
starting in 2022 in the European Union, zinc use in such
high concentrations will be banned [3, 4]. This is be-
cause zinc requirements for piglets are only 80 to 100
mg/kg [5] and therefore high medication doses of zinc
are not utilized by the animals and can result in environ-
mental contamination [6, 7]. In fact, it has been shown
that pig farm sites have high concentrations of zinc in
the soil [8]. Moreover, the high zinc doses (2500 mg/kg
diet) affect the intestinal microbiota, and there is also
evidence for co-selection of the antibiotic resistance
traits [9, 10].
Zinc nanoparticles (ZnNPs) can be an excellent alter-
native to high doses of zinc, in terms of higher pharma-
cokinetic efficiency, especially when used against
coliform bacteria in other mammals [11]. ZnNPs (450
mg/kg diet) significantly reduced the Escherichia coli
population in the small and large intestine in weaned
piglets. Furthermore, it lead to much lower excretion of
zinc in the feces in comparison to that of the same dose
of ZnO [12]. It has been demonstrated that ZnNPs in
pig nutrition can reduce the zinc use up to 60% while
maintaining the same positive effect on the intestinal
microbiome [13]. Nevertheless, there are many questions
remaining about the safety of nanoparticles and their
metabolites for animals and their fate and the effect
on the environment. For example, it has been shown
that some nanoparticles may impair the growth of
aquatic plants [14]. Zinc is also a strong antioxidant
related to the protection of porcine dermis and its
derivatives [15, 16].
Based on our previous work, where four types of
ZnNPs were characterized and tested on rats [11], the
two types of antibacterial zinc phosphate-based NPs
were studied as alternatives to ZnO in the diet of
weaned piglets. ZnNPs positively influenced the growth
performance of piglets compared to that of control.
Moreover, the effect of ZnNPs on the intestinal micro-
biome, antioxidant markers, intestinal and liver




All chemicals were purchased from Sigma Aldrich (St. Louis,
MO, USA) and Penta (Prague, Czech Republic) of p.a. purity,
unless noted otherwise. The pH was measured using inoLab
Level 3 (Wissenschaftlich-Technische Werkstatten GmbH;
Weilheim, Germany). Deionised water underwent deminer-
alisation by reverse osmosis using the instruments Aqua Os-
motic 02 (Aqua Osmotic, Tisnov, Czech Republic) and then
it was subsequently purified using Millipore RG (Millipore
Corp., Waltham, MA, USA) – 18 MΏMilliQ water.
ZnNPs synthesis
The phosphate-based ZnNPs were synthesized according
to the procedure published in our previous study [11].
Briefly, ZnA NPs were prepared by dissolving of
Zn(NO3)2·6H2O (44.6 g) in 500mL of milliQ water and
heating to 60 °C. Then, 13.2 g of (NH4)2HPO4 dissolved
in 200 mL of milliQ water was added. After 2 h of stir-
ring, the mixture was made up to 1000mL with milliQ
water. The ZnC NPs were prepared by dissolving of
Zn(NO3)2·6H2O (30 g) in 500mL of milliQ water and
heating to 60 °C. Then, 13.3 g Na4P2O7 dissolved in 200
mL of milliQ water was added. After 2 h of stirring, the
mixture was made up to 1000 mL with milliQ water.
Animal experiment
The experiment was performed with the approval of the
Ethics Committe at the Faculty of AgriSciences, Mendel
University in Brno, Czech Republic in accordance with
the Act No. 246/1992 Coll. on the protection of animals
against cruelty.
Proposed experiment was conducted on an accredited
experimental farm of the Research Institute of Animal
Production in Prague (Czech Republic). The experiment
was carried out on weaned piglets divided into 10 groups
with 10 animals in each group. The sex ratio in the
group was 50:50 (castrates:females). The first group
served as control, where zinc intake was not manipu-
lated in the diet. The second, third, and fourth group
were supplemented with zinc in the form of ZnO at a
dose of 500, 1000, and 2000mg of Zn equivalent per
kilogram of diet, respectively. The fifth, sixth and
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seventh groups of piglets were supplemented with ZnA
nanoparticles at a dose of 500, 1000 and 2000mg of Zn
equivalent per kilogram of diet, respectively. The last
tested supplementation was ZnC nanoparticles, which
were added to the eighth, ninth, and tenth group of pig-
lets at doses of 500, 1000 and 2000mg of Zn equivalent
per kilogram of diet, respectively.
The experiment started on the weaning day of the piglets
(day 28 of the animal age), and the Zn feeding lasted for 10
days. Different forms of zinc were mixed into the piglet
mixture (Table 1 and Table S1). The total content of phos-
phorus in the diet was 6.49 g/kg —calculated by the feed
program Agrokonzulta (Czech Republic). The piglets had a
feed and water available ad libitum. The animal husbandry
complied with Decree No. 208/2004 Coll. (Decree on mini-
mum standards for the protection of farm animals).
Before starting the experiment, piglets were weighed,
and 10 mL of blood from vena jugularis externa was col-
lected and aliquotted in two tubes by a veterinarian. At
the end of the feeding stage of the experiment (10 days),
body weight and blood collection were conducted as de-
scribed above. Three piglets (females) were sacrificed
from each group, and the liver and the small intestine
(1/3 of the duodenum) were collected for histological
analysis. Generally, females have more sensitive antioxi-
dant system than males. Moreover, females are more
susceptible to acute liver injury from xenobiotics than
males [17–19]. The samples were fixed in a 10% forma-
lin solution. The sacrificing of piglets was performed
with the Exagon® anaesthetic (400 mg/mL). Piglets were
given general anesthesia with a combination of Xylazine®
and Ketamine®. Remaining piglets were weighed again at
the end of the experiment on day 20.
Quantitative and qualitative analysis of the microbiome
in piglet feces
Fresh fecal samples were collected from individual pig-
lets immediately before the start of the zinc treatment
(day 0) and then on day 5, 10 and 20. The fresh feces
were sampled into sterile collection tubes, kept on wet
ice and processed within 4 h. Determination of the total
aerobic microorganisms and the total coliforms count
was performed. In addition, qualitative identification of
the major bacterial groups was conducted. Both analyses
were carried out separately for each sample. The fecal
samples were homogenized in sterile 0.85% saline (1:9w/
v), and the homogenate was then serially diluted. Subse-
quently, 1.0 mL of diluted suspension was pour plated
on the Plate Count agar (PCA) and MacConkey agar
(Sigma-Aldrich) in duplicates. All colonies from PCA
and from MacConkey agar were counted after 24 h at
37 °C. The results are expressed as log(CFU/g) of feces.
For identification of the major groups of bacteria, the
fecal samples were applied on selective agars designed
for growth of E. coli and coliforms (HiCrome Chromo-
genic Coliform HiCynth agar, Himedia, India), strepto-
cocci, and enterococci (Columbia blood agar with
Streptococcus selective supplement, Oxoid, UK; Mitis
Salivarius agar, Sigma-Aldrich). Representative individual
colonies were picked from each agar plate and streaked
on 5% blood sheep agar and incubated at 37 °C for 24 h.
Individual isolates were identified by the matrix-assisted
laser desorption/ionization time-of-flight mass spectrom-
eter (MALDI-TOF MS) Bruker ultrafleXtreme (Bruker
Daltonik GmbH, Bremen, Germany) using MALDI BioTy-
per™ Compass Explorer 4.1.90 analysis software equipped
with MBT 8468 MPS library. Bacterial isolates were then
stored at − 80 °C for further analysis.
E. coli virulence factors
Confirmed E. coli isolates were screened for five viru-
lence factors (F18, F4, STa, STb, Stx2) and one house-
keeping gene (uidA) by multiplex PCR. Briefly, a loopfull
of each isolate was transferred to 200 μL of sterile dis-
tilled water in a 1.5 mL sterile microcentrifuge tube.
Cells were lysed by boiling for 10 min, incubated on ice
for 5 min, and centrifuged for 2 min at 13500×g. Three
microliters of the supernatant were used per PCR reac-
tion. The following E. coli strains were used as positive
controls: E. coli 13502 (for Stx2 and F18), E. coli 10423
(for STa, STb, and F18) and E. coli 11803 (for STb and
F4). E. coli 7929 (from the Czech Collection of Microor-
ganisms, Brno) was used as a non-pathogenic (negative)
control. The mixture for PCR reaction (25 μL) was com-
posed of 12.5 μL Q5 Hot Start High Fidelity 2X Master
Mix (NEB, USA), 0.3 μL of primers for Stx2 (VT2,
10 μmol/L) and F18 (10 μmol/L), 0.46 μL of STb primers
(10 μmol/L) and 0.63 μL of STa primers (10 μmol/L),
Table 1 Composition of the diet
Component Quantity, %
Barley seed 41.2
Grain selvico test 25.0
Wheat seed 17.4
Dried poultry blood 4.5
Trace mineral-vitamin premixa 3.8
Wheat bran 3.0




aSupplied per kilogram diet as feed basis: vitamin A, 5000 IU; vitamin D3, 800
IU; vitamin E, 30 IU; vitamin K3, 1.0 mg; biotin, 0.05 mg; folic acid, 0.3 mg;
niacin, 10 mg; D-pantothenic acid, 10 mg; riboflavin, 3.6 mg; thiamine, 1.0 mg;
pyridoxin, 1.5 mg; choline, 800 mg; Zn (ZnSO4), 120 mg; Fe (FeSO4), 125 mg; Cu
(CuSO4·5H2O), 15 mg/kg; Mn (MnSO4·H2O), 10 mg/kg; I (KI), 0.15 mg; Se
(Na2SeO3), 0.2 mg; enramycin, 20 mg; chlortetracycline, 50 mg
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6.14 μL of deionized water and 3 μL of lysate. The sec-
ond reaction was performed for F4 and uidA. The mix-
ture for PCR reaction (25 μL) was composed of 12.5 μL
Q5 Hot Start High Fidelity 2X Master Mix (NEB, USA),
0.625 μL of F4 primers (10 μmol/L), 1 μL of uidA
primers (10 μmol/L), 6.25 μL of deionized water and
3 μL of lysate. Primers used in this study are described
in Table 2. Amplification was done on a Mastercycler
nexus (Eppendorf, Germany). Cycling conditions were as
follows: 90 °C for 5 min, 35 cycles of 90 °C for 1 min,
61 °C for 1 min, 72 °C for 1 min, followed by 72 °C exten-
sion for 10 min and 4 °C hold. The PCR products were
visualized by gel electrophoresis using 1.5% agarose
(Sigma Aldrich, USA).
Glutathione peroxidase analysis
The activity of glutathione peroxidase (GPx) was carried
out according to the protocol of RANSEL (Randox, United
Kingdom). Briefly, GPx catalyzed the glutathione (GSH)
oxidation by peroxide to its oxidized form (GSSG). In the
presence of glutathione reductase and NADPH, GSSG is
converted to GSH and simultaneously the NADPH is oxi-
dized to NADP+ which is accompanied by a change in ab-
sorbance maximum. The analysis was carried out on the
spectrophotometer Secomam S.500P (Secomam, USA) with
absorbance wavelength set to 340 nm.
Malondialdehyde analysis
Determination of malondialdehyde (MDA) was carried
out using the spectrophotometer Agilent Cary 60 (Agi-
lent, USA). MDA is one of the secondary products of
lipid peroxidation. At elevated temperature, a red com-
plex with thiobarbituric acid (TBA) forms in an acidic
environment. The absorbance of the resulting color
complex MDA-TBA is measured at three wavelengths of
485 nm, 532 nm, and 560 nm.
Zinc detection
Zinc concentration was determined by the atomic ab-
sorption spectrometer with flame and electrothermal
atomization Varian AAS DUO 280 Z + 240 FS – FAAS
flame technology (Agilent, USA).
Statistical analysis
The bacterial counts were analysed using IBM SPSS Sta-
tistics 21 (IBM Corporation, Armonk, New York, USA)
and the differences with P < 0.05 were considered as sig-
nificant. Zinc concentration (0, 500, 1000 and 2000mg/
kg), treatment group (ZnA, ZnC and ZnO) and time
period (0, 5, 10 and 20 days) were treated as categorical
data types throughout all tests. Extreme (far) outliers of
the total and coliform counts were removed according
to boxplots of treatment groups and Zn concentration in
each time period. Extreme outliers were values outside
the 3× interquartile range, which most likely resulted
from errors in pipetting and dilutions. Near outliers
(outside the 1.5× interquartile range) were retained.
In each Zn treatment group, analysis of variance
(ANOVA) test was used to detect significant differences
in microbial growth based on Zn concentrations. Pair-
wise comparisons based on the weighted average of
“Studentized” ranges were done using the Dunnett’s C
post hoc test for unequal variances. The paired T-test
was used to study significant differences in microbial
growth between time periods and day zero.
The comparison between treatment groups and ZnO
group was performed using independent sample T-test
and Mann Whitney test. Due to the frequent signifi-
cance in Levene test of equal variances and inconsisten-
cies in T-test results, the non-parametric Mann Whitney
test results were considered more reliable in this part of
the study.
To study the significance of Zn treatments and dosage
as risk factors for diarrhea, adjusted odds ratios (OR)
Table 2 Primers used virulence factor detection
Virulence factor Primer sequence (5′→3′) PCR product size, bp Reference
F18 TGGTAACGTATCAGCAACTA 313 [20]
ACTTACAGTGCTATTCGACG
F4 GCCTGGATGACTGGTGATTT 709 [21]
TCTGACCGTTTGCAATACCC
STa CAACTGAATCACTTGACTCTT 158 [20]
TTAATAACATCCAGCACAGG
STb TGCCTATGCATCTACACAAT 113 [20]
CTCCAGCAGTACCATCTCTA
Stx2 (VT2) GTTTTTCTTCGGTATCCTATTCC 484 [22]
GATGCATCTCTGGTCATTGTATTAC
uidA TGTTACGTCCTGTAGAAAGCCC 153 [23]
AAAACTGCCTGGCACAGCAATT
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were calculated by binary logistic regression. The event
of diarrhea was used as dependent variable with binary
0/1 values. Covariates were added via a×b entry method
to calculate cross-adjusted OR. Confidence interval (CI)
for OR were calculated at 95%.
The data for antioxidant status and Zn levels were
analyzed using STATISTICA.CZ, version 12.0 (Czech
Republic). The results were expressed as a mean from all
samples ± standard deviation. Statistical significance was
determined by examining the basic differences among
groups using ANOVA and Scheffé’s method for all pa-




Piglets had a mean weight between 6.0 and 8.1 kg in dif-
ferent groups at the start of the experiment (Table 3).
The control group had a weight gain of 2.0 kg after 20
days. At a dose of 500 mg Zn/kg diet, the highest weight
increase was observed in the group of piglets with ZnA
NPs (3.7 kg). Piglets fed a Zn dose of 1000mg/kg diet
had the highest weight increase in the ZnA group (3.7
kg). At the dose of Zn 2000 mg/kg diet, the highest
weight increase was also observed in the ZnA group
(4.4 kg). Overall, significantly higher weight gains (P <
0.05) were observed in ZnA piglet groups compared to
that of the control group at all Zn concentrations. The
increase was 2.5 kg, 2.7 kg, and 3.4 kg for Zn dose 500,
1000, and 2000 mg Zn/kg diet, respectively. Also, group
ZnC (dose 2000mg/kg) and ZnO (1000 mg/kg) showed
a significant increase (P < 0.05) in weight compared to
that of control. Significant differences in weight gain
were not observed between groups supplemented with
zinc nanoparticles (ZnA, ZnC) and ZnO. Body weight
gain was highest in the ZnA 2000 mg/kg group (4.4 kg).
The lowest body weight gain was observed in the control
group (2.0 kg).
Effect of Zn treatments on aerobic bacteria and coliforms
counts
The counts of total aerobic bacteria determined in piglet
feces over 20 days are shown in Fig. 1. The overall
average counts were 7.71 × 108 CFU/g feces for ZnA,
2.76 × 109 CFU/g for ZnC, 1.06 × 109 CFU/g for ZnO,
and 4.28 × 109 CFU/g for the control group. Compared
with the control group, the significant difference
(P < 0.05) was determined for ZnA (500 and 1000mg/
kg), ZnC (500, 1000, and 2000mg/kg), and ZnO (500
and 1000 mg/kg) at day 0 (Fig. 1a). Then, the significant
decrease (P < 0.05) was observed at day 20 (Fig. 1d) in
the case of ZnA (500, 1000, and 2000mg/kg) and ZnO
(500 and 2000 mg/kg) compared with the control group.
When comparing the NPs treatment with ZnO, the sig-
nificant mean difference was found between ZnA and
ZnO at day 5 (1000mg/kg) and day 20 (2000 mg/kg)
when ZnA counts were significantly higher (P = 0.021)
on 5th day and conversely significantly lower (P = 0.026)
on 20th day (Fig. 1b, d). Between ZnC and ZnO, the sig-
nificant differences were found at day 5, 10 and 20 (Fig.
1b, c, d). Specifically, ZnC (1000 and 2000mg/kg) showed
a significant decrease (P < 0.001) in counts at day 5, while
on the 10th day of treatment, all concentrations of ZnC
caused significantly increased bacterial growth (P < 0.01).
The significantly higher (P = 0.01) counts for ZnC (1000
mg/kg) were also observed on day 20 compared to ZnO.
The change of coliforms counts in piglet feces during
the treatment is presented in Fig. 2. The overall mean
coliforms counts were calculated as 1.36 × 107 CFU/g
feces for ZnA, 8.71 × 106 CFU/g for ZnC, 6.42 × 107
CFU/g for ZnO, and 7.76 × 107 CFU/g for the control
group. The coliform concentration was significantly
lower (P < 0.05) in ZnC group (1000 and 2000mg/kg) at
day 0 compared to the control (Fig. 2a). Interestingly,
the significant increase (P < 0.05) of coliforms was ob-
served in ZnA (1000 mg/kg, day 10) and ZnC (2000 mg/
kg, day 20) groups in comparison with the control (Fig.
2c, d). When comparing ZnO with NPs treatment, the
difference in coliforms growth was significant on all col-
lection days. The coliforms counts were significantly
higher for ZnO group in comparison to that in ZnA
group 1000 (P = 0.035) and 2000mg/kg (P = 0.002); and
also ZnC group 1000 (P = 0.001) and 2000 mg/kg
(P = 0.003) at day 0 (Fig. 2a). In contrast, on day 5 (Fig.
2b), the coliform concentration significantly increased
(P = 0.027) for ZnA (1000 mg/kg). ZnC treatment (1000
Table 3 Piglet weight during the experiment
Day Control 500 mg/kg 1000mg/kg 2000mg/kg
ZnO ZnA ZnC ZnO ZnA ZnC ZnO ZnA ZnC
0 6.6 ± 1.3 7.1 ± 0.4 7.4 ± 0.9 6.0 ± 0.9 7.9 ± 1.2 7.6 ± 1.7 6.8 ± 1.8 7.0 ± 0.9 7.6 ± 1.5 8.1 ± 0.9
10 7.7 ± 1.0 8.6 ± 1.1 8.6 ± 1.1 8.0 ± 1.1 9.0 ± 1.4 7.5 ± 1.3 9.1 ± 1.7 8.6 ± 1.1 8.9 ± 1.5 10.3 ± 0.9*
20 8.6 ± 1.5 9.9 ± 1.1 11.1 ± 0.9* 9.2 ± 1.1 11.5 ± 0.9* 11.3 ± 1.0* 9.8 ± 1.0 9.9 ± 1.3 12.0 ± 1.8* 10.9 ± 1.0
WG 2.0 ± 0.7 2.8 ± 1.4 3.7 ± 0.8* 3.2 ± 0.7 3.6 ± 0.8* 3.7 ± 1.6 3.0 ± 0.8 2.9 ± 0.9 4.4 ± 1.0* 2.8 ± 0.9
WG weight gain (difference between average weight on day 0 and day 20)
*indicates significant differences (P < 0.05) between the control and the treated group
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and 2000mg/kg) caused a significant decrease (P < 0.05)
of the coliforms concentration at day 5 of treatment
compared to that of ZnO. At day 10 of the treatment
(Fig. 2c), the similar pattern to that on day 5 was found.
ZnA (500 mg/kg) exhibited significant increase (P =
0.017) of coliforms; however, the counts significantly de-
creased (P < 0.01) in the case of ZnC treatment (1000
and 2000 mg/kg). And vice versa, compared to ZnO the
coliforms growth was significantly higher (P = 0.014) at
day 20 (Fig. 2d) for ZnC (2000 mg/kg).
The temporal comparison showed significant changes
between day 0 and the rest of the days in all treatments
(Fig. S1, note: controls were removed from paired T-
test). During ZnA treatment (Fig. S1A, B), paired-mean
total CFUs was significantly lower (P = 0.038) in day 10
compared to day 0 by 2.79 × 108 CFUs. Whereas paired-
mean total CFUs was significantly higher (P < 0.001) on
day 20 compared to day 0 by 1.30 × 109 CFUs. Paired-
mean coliform counts were significantly lower (P =
0.003) in day 20 compared to day 0 by 1.23 × 107 CFUs.
Moreover, significant positive moderate correlation
(R2 = 0.449, P = 0.021) was observed in coliforms be-
tween day 0 and day 5. After ZnC treatment (Fig. S1C,
D) paired-mean total counts were significantly higher
(P < 0.001) on day 10 compared to day 0 by 2.25 × 108
CFUs. The significantly higher (P < 0.001) counts were
also observed in day 20 compared to day 0 by 6.72 × 109
CFUs. In contrast, the coliforms counts were signifi-
cantly lower (P < 0.001) on day 10 compared to day 0 by
7.61 × 106 CFUs and significant reduction (P = 0.005)
was found on day 20 compared to day 0 by 7.65 × 106
CFUs. In ZnO treatment (Fig. S1E, F) paired-mean total
counts were significantly higher (P < 0.001) on day 20
compared to day 0 by 2.53 × 109 CFUs. Coliform counts
were significantly lower (P = 0.03) on day 5 compared to
day 0 by 1.60 × 108 CFUs and significantly lower (P =
0.006) as well on day 10 compared to day 0 by 2.25 × 108
CFUs.
Zn treatment and dosage as risk factors for piglet
diarrhea
To further investigate the role of Zn treatments and dos-
age as risk factors for piglet diarrhea, binary logistic
regression was used for calculating cross-adjusted OR.
Interestingly, the increase in log10CFU of coliforms
(cross-adjusted with either Zn treatment or concentra-
tion) was significantly more associated with diarrhea
events in most cases compared to total counts log10CFU
(see Additional file Table S2).
Fig. 1 Total counts of aerobic bacteria at day 0 (a) and after 5 days (b), 10 days (c) and 20 days (d) of Zn treatment. Boxes represent Q1 and Q3 quartiles
with median bar while T-whiskers represent 95% confidence intervals of 6–10 individuals. * indicates significant differences (P< 0.05) between group
without treatment (0) and groups with Zn treatment. # indicates significant differences (P< 0.05) between ZnA and ZnO group (the equal Zn
concentrations were compared). Δ indicates significant differences (P< 0.05) between ZnC and ZnO group (the equal Zn concentrations were compared)
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Based on Zn concentrations, total counts log10CFU cross-
adjusted with 1000 and 2000mg/kg at day 5 significantly in-
creased the risk of diarrhea by 1.814 (P = 0.002) and 1.622
(P= 0.012) folds, respectively, compared to that of the con-
trol group. There was no significant risk of diarrhea for
other Zn concentrations cross-adjusted with total log10CFU.
According to treatment types, total log10CFU cross-adjusted
with ZnA at day 5 significantly increased the risk of diarrhea
by 1.448 folds per increments of log10CFU units (P= 0.006).
There was no significant risk of diarrhea in remaining treat-
ment types cross-adjusted with total log10CFU. According
to Zn concentration, coliform log10CFU cross-adjusted with
most Zn concentrations at all times significantly increased
the risk of diarrhea by 1.628–2.918 folds, except for
log10CFU cross-adjusted with 500mg/kg at day 0, and also
500 and 2000mg/kg at day 20. Based on treatment types,
coliform log10CFU cross-adjusted with most treatment types
at all times significantly increased the risk of diarrhea by
1.804–2.811 folds, except for log10CFU cross-adjusted with
ZnC at day 0, ZnO and ZnC at day 20.
Overall, the risk of diarrhea due to increase in coli-
form log10CFU was highest in ZnA followed by ZnC,
followed by ZnO, and control, except on day 5 where
ZnC and ZnO treatment showed similar risks. The
risk of diarrhea due to an increase in total log10CFU
was highest in ZnA although it was only significant
on day 5.
Effect of Zn treatment on the diversity of culturable bacteria
The diversity of culturable bacteria was assessed from
the same fecal samples taken for evaluation of bacterial
concentrations. The results were analyzed as a relative
abundance of cultivable bacterial taxa for every piglet
group (Fig. 3). Escherichia sp. were present in all piglet
groups at all time points. Staphylococci were found in
piglet feces from all ZnO treatment groups. The ZnA
group also showed a higher prevalence of Streptococcus
sp. and Lactobacillus sp. Also, Enterococcus, Aerococcus
and Corynebacterium taxa were observed in most of the
groups and time points to some extent.
On the day 0, the piglets were weaned and fed with diet
containing ZnO and ZnNPs. At that time, the majority of
bacteria belonged to Escherichia (28.57–47.62%), Entero-
coccus (3.85–35.71%), Streptococcus (3.70–42.31%), Lacto-
bacillus (0–14.71%) and Corynebacterium (0–27.27%)
taxa, but Staphylococcus, Aerococcus and Proteus taxa
were also present in low abundance. On the 10th day of
the experiment Lactobacillus sp. (0–50.00%) increased,
moreover, the group with the highest concentration of
ZnC also showed Lactococcus sp. (3.85%). High abundance
Fig. 2 Counts of coliforms at day 0 (a) and after 5 days (b), 10 days (c) and 20 days (d) of Zn treatment. Boxes represent Q1 and Q3 quartiles with
median bar while T-whiskers represent 95% confidence intervals of 6–10 individuals. * indicates significant differences (P < 0.05) between group
without treatment (0) and groups with Zn treatment. # indicates significant differences (P < 0.05) between ZnA and ZnO group (the equal Zn
concentrations were compared). Δ indicates significant differences (P < 0.05) between ZnC and ZnO group (the equal Zn concentrations
were compared)
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of Staphylococcus sp. (37.50–50.00%) was found in all
ZnO concentrations on the 20th day. There were two cases
of piglets where Yersinia enterocolitica was found (ZnA
2000mg/kg, and ZnC 500mg/kg).
An occurrence of virulence factors in E. coli
The 542 of E. coli isolates were screened for five virulence
genes (STa, STb, Stx2, F4, F18). These genes have oc-
curred independently or in combinations (Table 4). Only
five positive isolates were found at day 0 (two in the con-
trol group, two in ZnC 500mg/kg, one in ZnO 2000mg/
kg). Presence of virulence genes dramatically increased on
day 5. All piglets from the control group carried E. coli
positive for STb/F4 or STb/F18. Moreover, one piglet was
positive for F4 alone. Similar situation was in piglets group
fed with ZnA. All piglets from the group ZnA 1000 and
2000mg/kg diet, and nine from ZnA 500mg/kg diet were
positive for virulence factors. The most common genotype
was STb/F4. In the case of ZnC 500mg/kg, there was a
high incidence of isolates with virulence genes, mostly
STb/F18. At a dose of 1000mg/kg and 2000mg/kg of
ZnC and in the group of ZnO 500mg/kg, all piglets were
negative for all virulence genes screened. In contrast, in
groups of ZnO 1000 and 2000mg/kg, six piglets were
positive, primarily for STb/F4.
Compared to day 5, we did not detect any virulence
factors in E. coli isolates in the control group at day 10
and only two positive piglets were revealed at the day
20. On day 10, there was still relatively high incidence of
virulence genes in the group of ZnA (6 or 7 positive pig-
lets in each group) and that decreased on day 20. Inter-
estingly, the dominant genotype was STb/F18 comparing
to that of day 5, where the most isolates were positive
for STb/F4. Overtime, an occurrence of virulence genes
increased in the group of ZnC. In contrast, in ZnA
group, the isolates with virulence traits decreased. Piglets
in the group of ZnO was mostly positive for E. coli with
the virulence genes through the entire experiment
(Table 4). However, we did not find any correlation be-
tween presence of virulence genes and piglet diarrhea.
Effect of Zn on antioxidant status
The significant differences after 10 days of treatment in
Zn level and and antioxidant status were observed only
in few cases. Compared to the control group, the level of
Zn in blood was even lower in treatements ZnO and
Fig. 3 The occurrence of cultivable bacterial genera in piglets feces (identified by MALDI-TOF MS)
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Table 4 Virulence genes in E. coli isolated from piglet feces





Control – 1 – – – – 1 – – – 15/2 2/0
ZnA 500 – 1/1a – – – – – 1 – – 16/2 2/1
ZnA 1000 – – – – – – – – – – 16/0 –
ZnA 2000 – – – – – – – – – – 13/0 –
ZnC 500 – – – – – – – – – – 15/0 –
ZnC 1000 – – – – – – – – – – 12/0 –
ZnC 2000 – – – – – – – – – – 10/0 –
ZnO 500 – – – – – – – – – – 11/0 –
ZnO 1000 – – – – – – – – – – 12/0 –
ZnO 2000 – – – – – 1 – – – – 16/1 1/0
Day 5
Control – – – 1 – 5/3 a 5/2 a – – – 12/11 10/5
ZnA 500 – 4 – 1/1 a – 4/1 a 1 1 – – 13/11 9/2
ZnA 1000 – 1 – 2/1 a – 7/4 a – 1 – – 12/11 10/5
ZnA 2000 – 3 – 1 – 8/3 a – – – – 12/12 10/3
ZnC 500 – – – 1 – 2 5/2 a – – – 12/8 8/2
ZnC 1000 – – – – – – – – – – 12/0 –
ZnC 2000 – – – – – – – – – – 11/0 –
ZnO 500 – – – – – – – 2 – – 11/2 2/0
ZnO 1000 – 1 – – 1 5/3 a – – – – 10/7 6/3
ZnO 2000 – – – – – 5/3 a – 1 – – 12/6 6/3
Day 10
Control – – – – – – – – – – 15/0 –
ZnA 500 – – – – – – 7/3 a – – – 8/7 7/3
ZnA 1000 – – – – – – 6/2 a 1 – – 11/7 6/2
ZnA 2000 – – – – – 4/1 a 3 1 – – 13/8 6/1
ZnC 500 – – – – – – – – – – 22/0 –
ZnC 1000 – – – – – 3 – – – – 5/3 3/0
ZnC 2000 – – – – – 2 – – – – 12/2 2/0
ZnO 500 – 2 – – – – 2 4 – – 26/8 5/0
ZnO 1000 – – – – – – 5 – – – 17/5 4/0
ZnO 2000 – – – – – 1 2 – – – 18/3 3/0
Day 20
Control – – – – – – – 3 – – 17/3 2/0
ZnA 500 – 1 – – – – – – – – 6/1 1/0
ZnA 1000 – 1 – – – – – – – – 7/1 1/0
ZnA 2000 – – – – – – – 4/2 a – – 11/4 2/1
ZnC 500 – 2 – – – – 2 – – – 22/4 4/0
ZnC 1000 – – – – – 2 1 – – – 15/3 3/0
ZnC 2000 – – – – – 2 5/1 a – – – 15/7 6/1
ZnO 500 – 5 2 – – – – – 2 1 14/10 5/0
ZnO 1000 – 7 – – 1 – – – – – 14/8 4/0
ZnO 2000 – – – – – – – 1 – – 11/1 1/0
a Number of genotypes associated with diarrhea
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ZnA at the lowest dose. Significantly different (P < 0.05)
Zn concentration was detected in piglet blood in the
dose of Zn 500mg/kg diet (Fig. 4a) between groups ZnO
(8.3 μmol/L) and ZnA (7.5 μmol/L). At a dose of 1000
mg/kg diet, no significant differences in zinc levels were
observed between the treated and control groups
(Fig. 44b). In the highest zinc concentration of 2000mg/
kg diet (Fig. 4c), a significant increase of Zn in blood
(P < 0.05) was observed in the ZnC group (19.6 μmol/L)
compared to that of the control group. The changes in
antioxidant status (GPx) was found only at ZnA treated
group. GPx significantly increased on day 10 (P < 0.05)
in the ZnA group in diets supplemented with 500, 1000,
and 2000 mg Zn/kg diet compared to that of the control
group (Fig. 4d-f). The GPx increase in the ZnA group
ranged from 35.0 to 48.8 U/g Hb. No significant differ-
ences were observed in any other groups (Fig. 4d-f). MDA
production was not significantly affected by Zn treatment
or concentration in any piglet group (Fig. 4g-i).
Effect of Zn on intestinal and liver morphology
Effects of ZnNPs and ZnO treatments on intestinal and
liver morphology are shown in Figs. 5 and 6. In the con-
trol group, small intestinal inflammations were observed
with enlarged spots coinciding with the villi (Fig. 5a).
Villlus atrophy occurred only sporadically with a number
of Brunner’s glands and malabsorption syndrome was
diagnosed. Minimal dystrophic changes were found in
liver samples (Fig. 6a). The group ZnA showed chronic
enteritis with plaque focal atrophy (Figs. 5b, h) and the
malabsorption syndrome. The villi were enlarged and
deformed (Fig. 5e). Cuticle and goblet cell showed normal
distribution. Liver parenchyma was affected by congestive
and full-area dystrophy with portobiliary dilution (Figs. 6b,
e, h). The small intestine of the ZnC treated group exhib-
ited inflammatory and atrophic changes, cuticle was in
norm (Fig. 5f, i). Mild enteritis and massive incidence of
goblet cells have been identified in ZnC treated group at a
dose of 500mg/kg (Fig. 5c). Congestive and dystrophic
liver parenchyma (Fig. 6c) as well as dilution of portobilis
(Fig. 6f, i) were also noticed. A group treated with ZnO
showed changes in the structure manifested by a large
number of goblet cells and chronic inflammation without
marked alteration of villi (Fig. 5d, g, j). The liver paren-
chyma in piglets fed with ZnO (Fig. 6d, g) showed chronic
inflammation with marked congestion. A full-area glyco-
gen hepatophilia with portobilitary dilatation was observed
in the group treated with ZnO at a dosage of 2000mg/kg
(Fig. 6j).
Discussion
Zinc (in the form of ZnO) is absorbed in the small intes-
tine by simple diffusion and via specific transporters.
Zinc enters the small intestinal mucosal cells by binding
Fig. 4 Concentration of zinc (a, b, c); glutathione peroxidase (d, e, f) and malondialdehyde (g, h, i) in blood samples. The applied concentrations
of zinc were 500, 1000 and 2000mg/kg
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to histidine, cysteine, and prostaglandins. Inside the in-
testinal mucosal cell, Zn is bound to the protein metallo-
thionein [24]. Zinc NPs have a higher solubility in the
gastrointestinal tract comparing to that of ZnO, and this
results in greater antibiotic effect leading to reduction in
diarrhea and higher weight gain [12]. The synthesis and
characterization of novel hydrogen phosphate-based
ZnA and diphosphate-based ZnC NPs were described in
our previous work. Moreover, the antibacterial potential
and the effect on the microbiota of rats and their overall
health was demonstrated [11]. In addition to body
weight increase, Zn NPs are able to positively affect the
feed conversion ratios [25]. It has been shown that a
dose of Zn (as ZnO) of 1200 mg/kg diet is sufficient to
improve intestinal integrity and consequently increase
the weight gain [26]. In our study, a significant positive
effect of ZnA in all concentrations was observed on the
weight of weaned piglets. In the dose of 500mg/kg and
1000 mg/kg of diet, the increment was 3.7 kg, which is
comparable with ZnO in the dose of 1000 mg/kg of diet.
The highest weight gain, 4.4 kg, was in the group of pig-
lets supplemented with ZnA in the dose of 2000 of mg/
kg diet. The use of ZnA in all concetrations approxi-
mately doubles weight increments when compared to
that of control. This does not fully correlate with the re-
sults of a study by Fernandes and colleagues, where the
weight of piglets was not affected by Zn dose (from 800
to 2500mg/kg diet) in the form of ZnO during 21 to 35
days [27]. Wang et al. [13] also demonstrated that ZnO
or ZnNPs (size 30 nm) in the dose of 3000 mg/kg diet
did not show a significant influence on piglets weight.
The body weight gain ranged from 2.54 to 3.09 kg dur-
ing the experiment [13]. However, our results show a
significant increase of weight in piglets fed with ZnO in
the dose 1000mg/kg of diet compared to that of control.
In another study, encapsulated zinc was tested at levels
of 800 (21 to 35 days of age) and 500 (36 to 49 days of
age) mg/kg diet. An average weight loss of 0.37 kg com-
pared to classical ZnO was observed at a dose of 2500
mg Zn/kg diet. A 35.8% increase in diarrhea incidence
Fig. 5 Histological analysis of piglets small intestine. Control (a), ZnA 500mg/kg (b), ZnC 500mg/kg (c), ZnO 500mg/kg (d), ZnA 1000 mg/kg (e),
ZnC 1000mg/kg (f), ZnO 1000mg/kg (g), ZnA 2000mg/kg (h), ZnC 2000 mg/kg (i), ZnO 200mg/kg (j)
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was observed in the zinc encapsulated group [27]. In our
study, we observed the opposite trend, all treatments
with ZnNPs led to greater weight gain comparing to that
of the control group with the largest increase of weight
gain in the ZnA group. It is known that weaning of pig-
lets causes a decrease in the level of zinc and this may
exacerbate problems at weaning (diarrhea, weight reduc-
tion) [28].
Understanding the composition of the microbial com-
munity and its functional capacity during weaning is
important for pig production since bacteria play an im-
portant role in swine health and growth performance. The
total number of culturable bacteria in control, ZnO and
ZnNPs groups showed increasing trend of CFUs per gram
of feces. Piglets overcome stress caused by dietary changes
during the weaning transition through a gut microbiome
shift and these results emphasize the importance of the
early-life microbiota [29]. Coliform bacteria, milk-
fermenting bacteria, and bacteria including Streptococcus
sp. and Enterococcus sp. are found in the gastrointestinal
tract after weaning commences [30]. Zinc feed additives
therefore seem to have no effect on the presence of the
most frequent representatives of coliforms and milk-
fermenting bacteria in the gastrointestinal microbiome.
There were no obvious differences in the bacterial diver-
sity between piglets on ZnO and ZnNPs, indicating they
have similar bactericidal effects. The majority of the bac-
teria were represented by Escherichia, Enterococcus,
Streptococcus, Lactobacillus and Corynebacterium taxa;
however, Staphylococcus and Proteus sp. were also present.
Nevertheless, there were two piglet cases, where Yersinia
enterocolitica was also found, one of which was presented
with bloody diarrhea (day 20, 2000mg ZnA per kg of
feed). In this case, the presence of heat-stable enterotoxin
in E. coli isolated from the same sample was also con-
firmed. Another strain of Y. enterocolitica was found in
the ZnC group (day 20, 500mg/kg), where the genes for
heat-stable enterotoxin and F18 fimbriae in E. coli were
Fig. 6 Histological analysis of piglets liver. Control (a), ZnA 500mg/kg (b), ZnC 500mg/kg (c), ZnO 500mg/kg (d), ZnA 1000mg/kg (e), ZnC 1000
mg/kg (f), ZnO 1000 mg/kg (g), ZnA 2000 mg/kg (h), ZnC 2000mg/kg (i), ZnO 200mg/kg (j)
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detected as well. Nevertheless, this piglet did not show any
diarrhea symptoms. It is, therefore, evident that the pres-
ence of potentially pathogenic bacteria does not necessary
lead to diarrhea. However, it is well known that a minimal
number of bacterial cells are required for colonization and
pathogenicity [31, 32], and our data show quantitative evi-
dence of the role of coliforms in risk of diarrhea (see Add-
itional file Table S2). In most of the studied Zn treatments
and concentrations, the increase in coliform CFU has in-
deed been shown to increase the likelihood of diar-
rhea. Additionally, it is important to add that diarrhea
is also influenced by the overall health status, and it
is therefore individual for each animal [33]. For ex-
ample, Colombo et al. demonstrated that ZnO NPs
affect the intestinal barrier. The in vitro barrier integ-
rity could be compromised depending on the size and
concentration of NPs and the proinflammatory cyto-
kine release was found [34]. Moreover, the oxidative
damage of intestinal epithelial cells by ZnO NPs was
shown and caused the disarragement of enterocytes’
cytoskeleton and cell junctions’ integrity [35].
Enterotoxigenic E. coli (ETEC) are among the most
important agents causing post-weaning diarrhea in pigs.
ETEC infection is often manifested as watery diarrhea
with decrease of weight and eventually death resulting in
serious economic losses. Presence of virulence genes in
ETEC differs between neonatal and weaned piglets. In
post-weaning piglets (PWD), the most common fimbrial
antigens are F4 (K88) and F18 [36, 37]. In our study, we
detected E. coli with these two fimbrial antigens as well.
Fimbriae F4 and F18 are responsible for E. coli adhesion
to the intestinal epithelium and colonization of the small
intestine. The most often enterotoxins in PWD are
thermostable toxins STa and STb and thermolabile toxin
[38, 39]. Our study focused on the detection of STa, STb
and on Shiga toxin Stx2 that cause hemorrhagic diar-
rhea. Our results showed presence of Stx2 only in 4 pig-
lets and none of them was associated with diarrhea. STa
and STb were detected mostly in combination with F4,
F18 or as STa/STb. It is known that fimbrial genes rarely
occur without other virulence traits [40]. In our study,
only a few E. coli isolates were positive for enterotoxins
alone. However, the prevalence of E. coli with virulence
traits varied over time. The majority of isolates positive
for virulence genes was found on the day 5, with the ex-
ception of piglets fed ZnC. It is very likely that the pig-
lets at this point were stressed out by weaning as well as
environmental and dietary changes which may have led
to the increase of ETEC. This was also the time with the
highest occurrence of diarrhea correlating with the de-
tection of ETEC. After that, the number of positive iso-
lates decreased in the control and ZnA groups. This
indicates that the recovery of normal microbiota in the
gut. In piglets in ZnC and ZnO groups, we did not
observe any significant changes in the number of ETEC
over time. As was mentioned above, presence of ETEC
does not necessarily leads to diarrhea. This is in agree-
ment with another study, where ETEC were detected in
subclinical infections in pigs [41]. Authors showed that
numerous ETEC can persist and circulate in a swine
population without clinical manifestation of diarrhea or
edema disease. This is important for diagnostics and epi-
demiology and for understanding the dynamics and ecol-
ogy of ETEC in pigs.
In the control group, half of the pigs got diarrhea by
the day 20 which is high occurrence compared to that of
the treated groups. This corresponds with the time the
gastrointestinal microbiome was expected to stabilize
after weaning. However, samples taken from the control
group did not have high prevalence of E. coli virulence
factors which indicates that diarrhea was caused by
other factors.
In previous studies, a higher Zn content in blood
serum increased by 6.8 resp. 9.7 mg/mL in weaned pig-
lets fed 450 or 3000mg Zn/kg diet [12]. In our study,
there was an increase in blood Zn concentration at the
dose of 2000 mg/kg diet. According to results reported
by Pei et al. [12], Zn in ZnNPs was mostly deposited in
the pancreas, and the majority of Zn was excreted in the
feces. This also in agreement with earlier observations,
that showed that linear increase in blood Zn concentra-
tion was observed after adding ZnNPs at 15, 30 or 60
mg Zn/kg of diet for 21 days in weaned piglets but other
blood parameters were not affected [42]. In another
study, the highest increase of Zn concentration in blood
plasma and pancreas was observed at a dose of 800mg
ZnNPs/kg of diet [13]. Using ZnNPs at a dose of 1200
mg Zn/kg diet, as in our experiment, a higher final
weight was observed when compared to that of the con-
trol group. Higher concentrations of zinc in plasma and
liver were also observed [43].
As seen from our results, it is necessary to focus not
only on the dose of ZnNPs, but also on the modification
of nanoparticles. In our study, we used phosphates
which may, to some extent, limit the absorption of Zn
into the body as also shown in our previous study [11].
At a dose of 2000mg kg/diet in the diet of rats, the in-
crease in Zn concentration in the blood, liver, and kid-
ney increased compared to that of the control group,
and this depended on the type of NPs modification.
Other MDA antioxidant parameters, superoxide dismut-
ase (SOD) and oxidized glutathione concentrations were
not affected. In another study, the dose of 10 mg
ZnNPs/kg of body weight fed to rats for 30 days resulted
in higher activity of SOD and GPx in the testicular tis-
sue. In contrast, the MDA level decreased [44]. These
results do not entirely correlate with our observation.
The antioxidant status of the organism was not
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significantly affected, except in the ZnA group of piglets
where we observed significantly higher GPx activity at
the 500, 1000 and 2000 mg/kg diet. ZnNPs were tested
in vitro using the antioxidant method of 2,2-diphenyl-1-
picrylhydrazyl (DPPH), which showed higher efficacy
compared to that of the control group and ZnO [45].
Also, Gupta et al. observed a higher antioxidant effect of
ZnNPs under in vitro conditions using the DPPH assay
and Free Radical Scavenging Activities (FRSA) [46]. In
contrast to our experiment, these results were ob-
tained under in vitro conditions. Also, the form and
modifications of ZnNPs were different from those
used in our study. In the long-term study (270 days)
on mice, the oxidative stress generation by Zn ions
and ZnO NPs treatment was not shown. The levels of
GSH and MDA in the liver and the lungs did not
change compared to that of control. Furthermore, the
fecal analysis showed two times higher Zn concentra-
tion than that in the control group indicating the
main route of Zn excretion [47].
In a previous study, piglets fed by nanozinc (1200 mg/
kg diet) showed increased crypt depth, villus length and
villus surface area in the ileum and the duodenum com-
pared to that of control (Zn 100 mg/kg diet) [43]. Similar
results were obtained in the study of Wang et al. [13],
where after supplementation of ZnNPs in the piglet’s
diet they observed higher villous height (by 30.9 μm),
crypt depth (by 20.2 μm), villous width (by 18.3 μm) and
villous surface compared to that of the control group.
The addition of 2500 mg/kg diet of ZnO increased the
length of the villus height in the jejunum and the ileum
by 23 and 22 μm, respectively, compared to that of con-
trol receiving 120 mg zinc per kg diet [48]. In our experi-
ment, malabsorption syndrome was diagnosed in the
control group and also in the group supplemented by
ZnA 2000mg/kg. This could be due to the combination
of the higher zinc dose and the form of ZnNPs based on
the hydrogen phosphate precursor. Malabsorption syn-
drome refers to a number of disorders in which the
small intestine cannot absorb enough nutrients and
fluids. Nutrients that the small intestine often has
trouble absorbing can include macronutrients (proteins,
carbohydrates, and fats), micronutrients (vitamins and
minerals) or both. Inadequate levels of these nutrients
can cause imbalance of antioxidant systems in the body
[49]. In the control group of piglets, where the malab-
sobtion syndrome was found, no zinc blood imbalance
was detected. Also, GPx activity and MDA concentra-
tions were not affected in this group. Other studies sug-
gest that the high doses of zinc (2500 mg/kg diet) also
affect the enzyme levels in the liver (e.g. arginase1, thio-
sulfate sulfurtransferase, HSP70), thus supporting the
hypothesis of intermediary effects of pharmacological
levels of zinc oxide fed to pigs [50]. ZnA and ZnC
nanoparticles were tested in a previous in vivo experi-
ment and did not show acute toxicity [11].
Due to the forthcoming ban of high pharmacological
doses of zinc in the European Union, the efforts are to
find alternatives to high-doses of dietary ZnO in pig pro-
ductions. The dietary supplementation with the low dose
(500mg/kg of diet) of porous Zn and ZnO NPs showed
similar or even greater effects on weight gain, intestinal
morphology, diarrhea occurrence, and intestine iflamation
in piglets compared to that of the high pharmacological
dose (3000mg/kg of diet) of ZnO [51]. Analogously, the
dose 600mg Zn/kg of diet of Zn NPs improved piglets
growth performance and reduced diarrhea incidence
which is comparable to the high dose of ZnO (2000mg
Zn/kg). The presumed mechanism is intestinal microbiota
alteration and inflammation response improvement [52].
However, the fate of the excreted nanoparticles and their
effect on the environment remain to be investigated.
Clearly, the bioavailability and the toxicity depend on
characteristics of different nanoparticles [53–55] and how
they interact with the organic matter in the soil [56].
Conclusion
Two formulations of Zn phosphate-based NPs were
tested as alternatives to ZnO, which is traditionaly used
as a dietary supplement in livestock productions. The
extensive use of high-dose dietary ZnO may result in a
long-term adverse effect on the environment, therefore
the application of lower-doses ZnNPs with the same ef-
fect on swine production could be a potential solution.
We demonstrate that dietary supplementations with
ZnA NPs significantly increased piglet weight gain even
at the lowest concentration (500 mg/kg) without any ser-
ious side effects on the piglets. In contrast, the highest
ZnO dose (2000 mg/kg) did not have a such effect. Our
results indicate that NPs are a promising alternative to
high pharmacological doses of conventional ZnO.
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